Welcome to LookChem.com Sign In|Join Free
  • or
(1S*,2R*,3S*)-2-methyl-3-phenylcyclopropane-1-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

24581-87-1

Post Buying Request

24581-87-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

24581-87-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 24581-87-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,5,8 and 1 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24581-87:
(7*2)+(6*4)+(5*5)+(4*8)+(3*1)+(2*8)+(1*7)=121
121 % 10 = 1
So 24581-87-1 is a valid CAS Registry Number.

24581-87-1Relevant academic research and scientific papers

Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation

Schulz-Fincke, Johannes,Hau, Mirjam,Barth, Jessica,Robaa, Dina,Willmann, Dominica,Kürner, Andreas,Haas, Julian,Greve, Gabriele,Haydn, Tinka,Fulda, Simone,Lübbert, Michael,Lüdeke, Steffen,Berg, Tobias,Sippl, Wolfgang,Schüle, Roland,Jung, Manfred

supporting information, p. 52 - 67 (2017/12/26)

FAD-dependent lysine-specific demethylase 1 (LSD1) is overexpressed or deregulated in many cancers such as AML and prostate cancer and hence is a promising anticancer target with first inhibitors in clinical trials. Clinical candidates are N-substituted derivatives of the dual LSD1-/monoamine oxidase-inhibitor tranylcypromine (2-PCPA) with a basic amine function in the N-substituent. These derivatives are selective over monoamine oxidases. So far, only very limited information on structure-activity studies about this important class of LSD1 inhibitors is published in peer reviewed journals. Here, we show that N-substituted 2-PCPA derivatives without a basic function or even a polar group are still potent inhibitors of LSD1 in vitro and effectively inhibit colony formation of leukemic cells in culture. Yet, these lipophilic inhibitors also block the structurally related monoamine oxidases (MAO-A and MAO-B), which may be of interest for the treatment of neurodegenerative disorders, but this property is undesired for applications in cancer treatment. The introduction of a polar, non-basic function led to optimized structures that retain potent LSD1 inhibitors but exhibit selectivity over MAOs and are highly potent in the suppression of colony formation of cultured leukemic cells. Cellular target engagement is shown via a Cellular Thermal Shift Assay (CETSA) for LSD1.

Stereochemistry of the transformations of gem-cyclopropanedicarboxylic acid to carboxybutyrolactones. II. Stereospecificity of the rearrangement of 2,3-diphenyl- and 2-methyl-3-phenyl-1,1-cyclopropanedicarboxylic acids

Mandel'shtam, T. V.,Kolesova, S. V.,Polina, T. V.,Solomentsev, V. V.,Osmolovskaya, N. S.

, p. 1024 - 1031 (2007/10/02)

When heated above melting points, cis- and trans-2,3-diphenyl-1,1-cyclopropanedicarboxylic acids lose carbon dioxide and are converted nonstereospecifically into a mixture of trans-3,4-diphenyl-γ-butyrolactone and trans-2,3-diphenyl-1-cyclopropanecarboxyl

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 24581-87-1